Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey

Yazar
Ok, Engin
Saip, Pinar
Uras, Cihan
Demircan, Orhan
Isikdogan, Abdurrahman
Ozmen, Vahit
Atasoy, Ajlan
Gökmen, Erhan
Ozdogan, Mustafa
Guler, Nilufer
Üst veri
Tüm öğe kaydını göster
Özet
Introduction: Breast cancer is the most common malignancy among Turkish women and the rate of early stage disease is increasing. The Oncotype DX (R) 21-gene assay is predictive of distant recurrence in ER-positive, HER2-negative early breast cancer. We aimed to evaluate the impact of the Recurrence Score (R) (RS) on treatment decisions and physician perceptions in Turkey. We also studied correlations between RS and routine risk factors.
Bağlantı
http://hdl.handle.net/20.500.12627/85356
https://doi.org/10.7759/cureus.522
Koleksiyonlar